Delivery booms and real estate busts: The split reality of Hong Kong’s 2026 marketGlobal Report·19 hours ago033770.00%02157+2.85%
Capital Shifts to Defensive ETFs as Mixed Earnings Signal Repricing Risks in Hong KongGlobal Report·21 hours ago02546-1.11%03738+0.60%
The Hong Kong Market's "Leftover" Bin: Who's Faking It and Who's Real?Global Report·Aug 19 at 04:44 AM01951+3.99%01875+0.12%
Hong Kong Niche Plays: Tech Upgrades and Fertility Turnarounds to WatchGlobal Report·Aug 19 at 04:42 AM01951+3.99%01187+1.06%
Divergent Signals from Hong Kong's Niche Sectors Highlight an Uneven RecoveryGlobal Report·Aug 11 at 04:43 AM01187+1.06%01770+2.65%
The Hong Kong Unbundling: Value Chains and the Niche Supplier OpportunityGlobal Report·Aug 6 at 04:15 AM01187+1.06%02522+4.43%
Cofoe Medical files HKEX next-day disclosure return on share repurchase for cancellationPUBT·Jul 28 at 04:50 AM01187+1.06%301087+3.58%
Hong Kong Mid-Caps Drive Summer Dealmaking Amid USD 2.3 Billion Bio-Licensing and Stock BuybacksGlobal Report·Jul 22 at 04:18 AM03692+0.76%01187+1.06%
The Strategic Divergence: When Real Estate Pivots to AI and Legacy Brands Seek New MoatsGlobal Report·Jul 15 at 04:14 AM01800+1.09%01798-0.43%
Hong Kong Healthcare and Industrials: RemeGen Advances as L.K. Tech Pivots to AI InfrastructureGlobal Report·Jul 9 at 09:02 PM09995+1.56%01187+1.06%
Pivots, Pitfalls, and the AI Mirage: Navigating Hong Kong's Fragmented 2026 MarketGlobal Report·Jul 9 at 05:03 AM03288+1.11%02338+2.54%
Cofoe Medical Technology Co. Ltd. Class H (1187) Receives a Buy from Exane BNP Paribasbusinessinsider·Jun 25 at 01:50 AM01187+1.06%
Brief News: COFOE MEDICAL's first listing fell nearly 6% in half a dayBambooWorks·May 6 at 12:31 AM01187+1.06%
